Fuji Pharma Co., Ltd. announced consolidated and non-consolidated earnings results for the year ended September 30, 2015. For the year, on consolidated basis, the company reported net sales of JPY 31,680 million compared to JPY 29,215 million a year ago. Operating income was JPY 3,251 million compared to JPY 3,173 million a year ago. Ordinary income was JPY 3,099 million compared to JPY 3,198 million a year ago. Net income attributable to common stock was JPY 2,092 million compared to JPY 2,078 million a year ago. EPS was JPY 137.55 against JPY 140.53 a year ago. Return on equity was 7.3% against 7.3% a year ago. Return on assets was 6.5% against 6.5% a year ago. Income before income taxes and minority interests was JPY 3,105 million compared to JPY 3,232 million a year ago. Net cash provided by operating activities was JPY 589 million compared to JPY 2,757 million a year ago. Purchase of property, plant and equipment was JPY 1,512 million compared to JPY 1,079 million a year ago. Purchase of intangible assets was JPY 31 million compared to JPY 942 million a year ago.

For the year, on non-consolidated basis, the company reported net sales of JPY 29,490 million compared to JPY 27,397 million a year ago. Operating income was JPY 3,337 million compared to JPY 3,319 million a year ago. Ordinary income was JPY 3,185 million compared to JPY 3,305 million a year ago. Net income was JPY 2,267 million compared to JPY 2,180 million a year ago. EPS was JPY 149.06 against JPY 147.38 a year ago. Income before income taxes was JPY 3,190 million compared to JPY 3,337 million a year ago.

For the year ending September 30, 2016, on consolidated basis, the company expects net sales of JPY 34,470 million, operating income of JPY 3,480 million, ordinary income of JPY 3,430 million and profit attributable to owners of the parent company of JPY 2,230 million or JPY 146.61 per share.

For the half year ending March 31, 2016, on consolidated basis, the company expects net sales of JPY 16,990 million, operating income of JPY 1,800 million, ordinary income of JPY 1,780 million and profit attributable to owners of the parent company of JPY 1,150 million or JPY 75.60 per share.

For the year ending September 30, 2016, on non-consolidated basis, the company expects net sales of JPY 32,360 million, ordinary income of JPY 3,470 million and net income of JPY 2,330 million or JPY 155.83 per share.

For the half year ending March 31, 2016, on non-consolidated basis, the company expects net sales of JPY 16,060 million, ordinary income of JPY 1,880 million and net income of JPY 1,260 million or JPY 84.27 per share.

The company announced dividend of JPY 24 per share for the year end of fiscal year 2015 compared to JPY 24 per share paid in the same period a year ago. The dividend will be payable on December 21, 2015.

The company provided dividend guidance for the year end of fiscal year 2016. For the period, the company expected dividend of JPY 24 per share compared to JPY 24 per share announced in the same period a year ago.